Kreylab
@kreylab.bsky.social
Veterinarian and Structural Virologist, fascinated by viruses and what we can do to combat them
Reposted by Kreylab
We are excited to highlight Eike's pivotal role in the DEFENDER consortium, a collaborative effort focused on uncovering viral entry factors. His research is vital in developing targeted strategies for preventing and controlling yellow fever virus (YFV) infections 🦟.
April 4, 2025 at 8:43 AM
We are excited to highlight Eike's pivotal role in the DEFENDER consortium, a collaborative effort focused on uncovering viral entry factors. His research is vital in developing targeted strategies for preventing and controlling yellow fever virus (YFV) infections 🦟.
Reposted by Kreylab
Eike Steinmann heads the Department of Molecular & Medical Virology at @ruhr-uni-bochum.de 🧬. His team is at the forefront of groundbreaking research, exploring RNA virus replication mechanisms and transmission routes, with a focus on flavi- and coronaviruses.
April 4, 2025 at 8:42 AM
Eike Steinmann heads the Department of Molecular & Medical Virology at @ruhr-uni-bochum.de 🧬. His team is at the forefront of groundbreaking research, exploring RNA virus replication mechanisms and transmission routes, with a focus on flavi- and coronaviruses.
Reposted by Kreylab
Spotlight on Marie Flamand
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
April 10, 2025 at 6:51 AM
Spotlight on Marie Flamand
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
Reposted by Kreylab
We're excited to share a recent SWR NANO feature highlighting DEFENDER that takes us behind the scenes of the impressive work done by the @chlandalab.bsky.social Lab at @uniheidelberg.bsky.social! 🧬 The feature starts at minute 18:58 – be sure to tune in!
👉 www.3sat.de/wissen/nano/...
👉 www.3sat.de/wissen/nano/...
April 10, 2025 at 8:02 AM
We're excited to share a recent SWR NANO feature highlighting DEFENDER that takes us behind the scenes of the impressive work done by the @chlandalab.bsky.social Lab at @uniheidelberg.bsky.social! 🧬 The feature starts at minute 18:58 – be sure to tune in!
👉 www.3sat.de/wissen/nano/...
👉 www.3sat.de/wissen/nano/...
Reposted by Kreylab
I am excited to share our study in Science on #measles fusion glycoprotein in complex with the first neutralizing antibody described for this virus! doi.org/10.1126/scie...
A neutralizing antibody prevents postfusion transition of measles virus fusion protein
Measles virus (MeV) presents a public health threat that is escalating as vaccine coverage in the general population declines and as populations of immunocompromised individuals, who cannot be vaccina...
doi.org
June 28, 2024 at 3:57 PM
I am excited to share our study in Science on #measles fusion glycoprotein in complex with the first neutralizing antibody described for this virus! doi.org/10.1126/scie...
Reposted by Kreylab
✨ Spotlight on @kreylab.bsky.social ! ✨
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
March 18, 2025 at 8:21 PM
✨ Spotlight on @kreylab.bsky.social ! ✨
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
Reposted by Kreylab
Our goal? To advance our understanding of host-pathogen interactions and uncover new viral entry factors, paving the way for innovative antiviral strategies against viral diseases with epidemic potential.
March 13, 2025 at 11:16 AM
Our goal? To advance our understanding of host-pathogen interactions and uncover new viral entry factors, paving the way for innovative antiviral strategies against viral diseases with epidemic potential.
Reposted by Kreylab
In the coming weeks, we’ll introduce you to the outstanding partners in our consortium – leading experts in virology, structural biology, and drug development – who are driving this crucial research forward. Stay tuned to learn more about their expertise and contributions!
March 13, 2025 at 11:16 AM
In the coming weeks, we’ll introduce you to the outstanding partners in our consortium – leading experts in virology, structural biology, and drug development – who are driving this crucial research forward. Stay tuned to learn more about their expertise and contributions!
Reposted by Kreylab
The DEFENDER project has officially launched!
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
DEFENDER
defender-project.org
March 13, 2025 at 10:56 AM
The DEFENDER project has officially launched!
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
Reposted by Kreylab
The deadline to apply for a travel grant to attend the CSSB symposium is this Friday, February 28.
To apply for the travel grant please complete the registration form and submit your scientific abstract.
symposium2025.cssb-hamburg.de/registration
@leibnizliv.bsky.social @uni-hamburg.de @embl.org
To apply for the travel grant please complete the registration form and submit your scientific abstract.
symposium2025.cssb-hamburg.de/registration
@leibnizliv.bsky.social @uni-hamburg.de @embl.org
February 26, 2025 at 9:13 AM
The deadline to apply for a travel grant to attend the CSSB symposium is this Friday, February 28.
To apply for the travel grant please complete the registration form and submit your scientific abstract.
symposium2025.cssb-hamburg.de/registration
@leibnizliv.bsky.social @uni-hamburg.de @embl.org
To apply for the travel grant please complete the registration form and submit your scientific abstract.
symposium2025.cssb-hamburg.de/registration
@leibnizliv.bsky.social @uni-hamburg.de @embl.org
Congrats to George Ssebyatika and Katja DInkelburg!!!!!!
February 26, 2025 at 7:02 PM
Congrats to George Ssebyatika and Katja DInkelburg!!!!!!
Happy to see this study published, a great collaboration between structural, molecular and clinical virology labs! We describe neutralizing antibodies targeting the Hepatitis E virus capsid protein that distinguish between infectious particles and antibody decoy.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice - Nature Communications
HEV-specific antiviral treatment is still lacking. Here, the authors functionally and structurally characterize broadly neutralizing antibodies isolated from HEV convalescent individuals and show that...
www.nature.com
February 26, 2025 at 7:01 PM
Happy to see this study published, a great collaboration between structural, molecular and clinical virology labs! We describe neutralizing antibodies targeting the Hepatitis E virus capsid protein that distinguish between infectious particles and antibody decoy.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Kreylab
Happy to join the Bluesky community! 🎉 Will try to share exciting research results, interesting events, announcements and reports about our research activities ...
January 16, 2025 at 10:03 AM
Happy to join the Bluesky community! 🎉 Will try to share exciting research results, interesting events, announcements and reports about our research activities ...